Fingerprint
Dive into the research topics of 'Phase 2 trial of single agent ipilimumab (Anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 trial of single agent ipilimumab (Anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma
Richard E. Royal, Catherine Levy, Keli Turner, Aarti Mathur, Marybeth Hughes, Udai S. Kammula, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Israel Lowy, Steven A. Rosenberg
Research output: Contribution to journal › Article › peer-review
582
Scopus
citations